AU601011C - Anti-inflammatory agents - Google Patents

Anti-inflammatory agents

Info

Publication number
AU601011C
AU601011C AU10164/88A AU1016488A AU601011C AU 601011 C AU601011 C AU 601011C AU 10164/88 A AU10164/88 A AU 10164/88A AU 1016488 A AU1016488 A AU 1016488A AU 601011 C AU601011 C AU 601011C
Authority
AU
Australia
Prior art keywords
inflammatory agents
inflammatory
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU10164/88A
Other versions
AU1016488A (en
AU601011B2 (en
Inventor
Nancy Grace Bollinger
Theodore Goodson Jr.
David Kent Herron
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of AU1016488A publication Critical patent/AU1016488A/en
Application granted granted Critical
Publication of AU601011B2 publication Critical patent/AU601011B2/en
Publication of AU601011C publication Critical patent/AU601011C/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU10164/88A 1987-01-12 1988-01-11 Anti-inflammatory agents Ceased AU601011C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US254287A 1987-01-12 1987-01-12
US002542 1987-01-12

Publications (3)

Publication Number Publication Date
AU1016488A AU1016488A (en) 1988-07-14
AU601011B2 AU601011B2 (en) 1990-08-30
AU601011C true AU601011C (en) 1993-01-21

Family

ID=

Similar Documents

Publication Publication Date Title
AU614965B2 (en) Thiadiazinones
AU5578390A (en) Dioxothiazolidine derivatives
AU1741788A (en) Azolylmethyl-cyclopropyl derivatives
AU2611588A (en) New phenylethanolamines
AU1407388A (en) Substituted di-t-butylphenols
AU2222388A (en) Peptidylheterocycles
AU1381888A (en) Timeswitches
AU1301788A (en) Chemo-radio-immuno-conjugates
AU2142288A (en) New aluminium-magnesium-hydroxy-compounds
AU1764488A (en) Substituted 5-methylamino-1-arylpyrazoles
AU2055488A (en) 7-Acylaminocephalosporin derivatives
AU2150088A (en) Isoxazole-beta-carboline derivatives
AU2665388A (en) 17-methylene-and 17-ethylidene-estratrienes
AU2345488A (en) Sanitizer
AU1590788A (en) Leukaemia-inhibitory factor
AU2784789A (en) Antisyncytial agent
AU1862088A (en) Hydroxyethyl-Azolyl derivatives
AU2586688A (en) Moth- and beetle-proofing agents
AU1158888A (en) Scraper-spreader
AU1366388A (en) Videosystem
AU2030288A (en) Anti-hyperlipemic agent
AU2431388A (en) Somototropin formulations
AU2021888A (en) Sulphonylaminoguanidinoazines
AU2456688A (en) Dripulator
AU2698888A (en) Naphthothiazepinones